48.68
-5.13%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥7.94bn
FY2018FY2025
Net income
CN¥945.8m
FY2018FY2025
Free cash flow
−CN¥79.0m
FY2018FY2025
Shareholders' equity
CN¥7.01bn
FY2018FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥7.94bn | CN¥5.23bn | CN¥4.39bn | CN¥4.78bn | CN¥2.34bn | CN¥681.9m | CN¥546.8m | CN¥468.8m |
| Gross profit | CN¥2.04bn | CN¥1.37bn | CN¥1.11bn | CN¥1.94bn | CN¥861.6m | CN¥248.3m | CN¥207.4m | CN¥187.3m |
| Research and development | CN¥251.0m | CN¥175.3m | CN¥124.8m | CN¥106.2m | CN¥54.8m | CN¥22.2m | CN¥20.1m | CN¥17.5m |
| Operating income | CN¥1.34bn | CN¥1.03bn | CN¥909.9m | CN¥1.60bn | CN¥664.9m | CN¥184.7m | CN¥111.9m | CN¥135.7m |
| Net income | CN¥945.8m | CN¥838.3m | CN¥722.9m | CN¥1.29bn | CN¥543.5m | CN¥152.6m | CN¥88.4m | CN¥115.4m |
| Diluted earnings per share | 3.63 | 3.22 | 2.76 | 6.63 | 2.79 | 0.59 | 0.34 | 0.44 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥11.74bn | CN¥9.26bn | CN¥7.42bn | CN¥8.87bn | CN¥3.67bn | CN¥1.50bn | CN¥958.5m | CN¥669.7m |
| Cash and short-term investments | — | CN¥685.6m | CN¥134.0m | CN¥2.15bn | CN¥120.9m | CN¥104.5m | CN¥21.4m | CN¥76.9m |
| Total liabilities | CN¥4.73bn | CN¥3.00bn | CN¥1.75bn | CN¥3.67bn | CN¥1.83bn | CN¥155.5m | CN¥115.0m | CN¥72.6m |
| Debt | CN¥1.90bn | CN¥1.76bn | CN¥1.10bn | CN¥1.69bn | CN¥273.2m | CN¥37.5m | CN¥11.1m | — |
| Shareholders' equity | CN¥7.01bn | CN¥6.27bn | CN¥5.66bn | CN¥5.20bn | CN¥1.84bn | CN¥1.35bn | CN¥843.5m | CN¥597.2m |
| Shares outstanding | 261m | 261m | 262m | 195m | 195m | 261m | 261m | 261m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥955.7m | −CN¥284.4m | −CN¥416.4m | −CN¥794.4m | −CN¥74.1m | −CN¥148.2m | −CN¥70.9m | CN¥15.9m |
| Capital spending | −CN¥1.03bn | −CN¥867.7m | −CN¥270.0m | −CN¥928.6m | −CN¥393.4m | −CN¥160.2m | −CN¥102.1m | −CN¥137.0m |
| Free cash flow | −CN¥79.0m | −CN¥1.15bn | −CN¥686.3m | −CN¥1.72bn | −CN¥467.5m | −CN¥308.4m | −CN¥172.9m | −CN¥121.1m |
| Dividends paid | −CN¥286.2m | −CN¥242.3m | −CN¥259.8m | −CN¥59.6m | −CN¥7.9m | −CN¥110,833 | −CN¥16.0m | −CN¥14,295 |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥2.31bn | CN¥2.20bn | CN¥2.44bn | CN¥2.12bn | CN¥1.76bn | CN¥1.63bn | CN¥1.61bn | CN¥1.53bn |
| Gross profit | CN¥402.0m | CN¥423.2m | CN¥447.6m | CN¥393.6m | CN¥415.8m | CN¥427.5m | CN¥453.8m | CN¥372.3m |
| Operating income | CN¥313.5m | CN¥351.1m | CN¥314.8m | CN¥274.2m | CN¥298.1m | CN¥296.1m | CN¥327.9m | CN¥286.6m |
| Net income | CN¥218.9m | CN¥180.8m | CN¥234.6m | CN¥231.9m | CN¥240.0m | CN¥239.2m | CN¥260.5m | CN¥221.1m |
| Diluted earnings per share | 0.84 | 0.69 | 0.90 | 0.89 | 0.92 | 0.92 | 1.00 | 0.85 |
| Cash from operations | — | — | — | −CN¥34.0m | CN¥590.0m | −CN¥1.03bn | CN¥250.0m | −CN¥414.0m |
| Capital spending | −CN¥462.0m | −CN¥290.0m | −CN¥661.0m | −CN¥116.0m | −CN¥139.0m | −CN¥116.0m | −CN¥259.0m | −CN¥215.0m |
| Free cash flow | — | — | — | −CN¥150.0m | CN¥451.0m | −CN¥1.14bn | −CN¥9.0m | −CN¥629.0m |
| Total assets | CN¥17.12bn | CN¥14.33bn | CN¥11.74bn | CN¥11.02bn | CN¥10.41bn | CN¥10.74bn | CN¥9.26bn | CN¥8.15bn |
| Cash and short-term investments | — | — | — | CN¥810.9m | CN¥275.8m | CN¥534.5m | CN¥685.6m | CN¥290.4m |
| Debt | CN¥4.94bn | CN¥3.82bn | CN¥1.90bn | CN¥1.56bn | CN¥2.67bn | CN¥2.88bn | CN¥1.72bn | CN¥1.41bn |
| Shareholders' equity | CN¥7.21bn | CN¥7.20bn | CN¥7.01bn | CN¥6.76bn | CN¥6.53bn | CN¥6.48bn | CN¥6.27bn | CN¥6.04bn |
Financial ratios
Data as of 27 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 25.7% | 26.1% | 25.3% | 40.5% | 36.9% | 36.4% |
| Operating margin | 16.9% | 19.7% | 20.7% | 33.4% | 28.5% | 27.1% |
| Net margin | 11.9% | 16.0% | 16.5% | 27.0% | 23.3% | 22.4% |
| Return on equity | 13.5% | 13.4% | 12.8% | 24.8% | 29.5% | 11.3% |
| Return on assets | 8.1% | 9.0% | 9.7% | 14.5% | 14.8% | 10.1% |
| Free cash flow yield | 16.0% | 4.7% | -1.2% | 1.4% | 3.4% | — |
| Revenue growth | 51.9% | 19.1% | -8.2% | 104.7% | 242.6% | 24.7% |
| Earnings growth | 12.8% | 16.0% | -43.9% | 137.3% | 256.2% | 72.5% |
| Current ratio | 2.97x | 3.39x | 3.99x | 1.84x | 1.53x | 6.19x |
| Debt to equity | 0.27x | 0.28x | 0.19x | 0.32x | 0.15x | 0.03x |
| Equity ratio | 59.7% | 67.6% | 76.4% | 58.6% | 50.2% | 89.7% |
| Interest coverage | 14.85x | 18.47x | 20.08x | 15.99x | 22.93x | 70.65x |
| R&D as a share of sales | 3.2% | 3.4% | 2.8% | 2.2% | 2.3% | 3.2% |
| Buybacks as a share of market value | -0.0% | 0.5% | -34.7% | 0.1% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 18.4% | 63.4% | — |
| Operating income | -5.6% | 48.7% | — |
| Net income | -9.8% | 44.0% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 25.9% | 28.9% | 29.8% | — |
| Operating margin | 18.0% | 21.8% | 22.6% | — |
| Net margin | 13.5% | 17.0% | 17.7% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 16.9 | 15.2 | 9.5 | 6.4 |
| Price to sales | 2.0 | 2.4 | 1.6 | 1.7 |
Dividends and splits
Per share, in the currency the company pays
Paid for 3 years. Last went ex-dividend on 3 Jul 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Paid in the year | 0.80 | 0.571 | 0.571 | 0.714 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.